Kairos Pharma
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
EBITDA | -880 | -182 | -247 | -1,049 |
EBIT | -920 | -222 | -287 | -1,089 |
Net Income | -1,047 | -253 | -323 | -1,118 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -2,020 | -168 | 36 | 66 |
Cash | 3,217 | 21 | 40 | 93 |
Basic Shares | 10,910 | 12,841 | 10,562 | 10,472 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
EBITDA | -1,554 | -431 | -1,883 | -1,046 |
EBIT | -1,714 | -591 | -1,981 | -1,045 |
Net Income | -1,812 | -1,050 | -2,145 | -1,051 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | 81 | -353 | -412 | -38 |
Cash | 93 | 437 | 73 | 14 |
Basic Shares | 10,382 | 10,236 | 12,841 | 11,215 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.10 |
